Microbot Medical receives new patent approvals in US, Japan, China and Canada

MBOT•2026-10-20

Microbot Medical received new patent approvals in the US, Japan, China and Canada on Oct. 20, 2026. Its portfolio now totals 44 issued patents and 49 pending applications.

1. Patent portfolio expands

Microbot Medical received new patents across North America and Asia on Oct. 20, 2026, bringing its global portfolio to 44 issued patents and 49 pending applications. The company said the expansion supports LIBERTY's U.S. commercialization and planned international growth as it pursues a CE mark.

Microbot Medical receives new patent approvals in US, Japan, China and Canada

1. Patent portfolio expands

Related News

Huron Consulting Group publishes update to financial calendar

Farmers & Merchants Bancorp Q3 net income rises 6% year over year to $25.1 million

Fortive's Accruent finds 58% less likely to attend or recommend colleges with repair backlogs or disruptions

Arqit invests in Sirius to expand quantum-safe defense communications

Waymo to launch autonomous ride-hailing in Madrid in 2027